The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Triene prostaglandins: Prostacyclin and thromboxane biosynthesis and unique biological properties
Open accessAbstract
Platelets enzymatically convert prostaglandin H 3 (PGH 3 ) into thromboxane A 3 . Both PGH 2 and thromboxane A 2 aggregate human platelet-rich plasma. In contrast, PGH 3 and thromboxane A 3 do not. PGH 3 and thromboxane A 3 increase platelet cyclic AMP in platelet-rich plasma and thereby: ( i ) inhibit aggregation by other agonists, ( ii ) block the ADP-induced release reaction, and ( iii ) suppress platelet phospholipase-A 2 activity or events leading to its activation. PGI 3 (Δ 17 -prostacyclin; synthesized from PGH 3 by blood vessel enzyme) and PGI 2 (prostacyclin) exert similar effects. Both compounds are potent coronary relaxants that also inhibit aggregation in human platelet-rich plasma and increase platelet adenylate cyclase activity. Radioactive eicosapentaenoate and arachidonate are readily and comparably acylated into platelet phospholipids. In addition, stimulation of prelabeled platelets with thrombin releases comparable amounts of eicosapentaenoate and arachidonate, respectively. Although eicosapentaenoic acid is a relatively poor substrate for platelet cyclooxygenase, it appears to have a high binding affinity and thereby inhibits arachidonic acid conversion by platelet cyclooxygenase and lipoxygenase. It is therefore possible that the triene prostaglandins are potential antithrombotic agents because their precursor fatty acids, as well as their transformation products, PGH 3 , thromboxane A 3 , and PGI 3 , are capable of interfering with aggregation of platelets in platelet-rich plasma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Radioimmunoassay for Cyclic Nucleotides
Steiner, A. L., Parker, C. W., & Kipnis, D. M. (1972) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)45621-4 · Cited by 2,026
EICOSAPENTAENOIC ACID AND PREVENTION OF THROMBOSIS AND ATHEROSCLEROSIS?
DYERBERG, J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91505-2 · Cited by 1,688
Prostaglandins: Their Disappearance from and Release into the Circulation
FERREIRA, S. H., & VANE, J. R. (1967) · Nature · doi:10.1038/216868a0 · Cited by 892
The chemical structure of prostaglandin X (prostacyclin)
Johnson, R. A., Morton, D. R., Kinner, J. H., et al. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90126-x · Cited by 729
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90048-4 · Cited by 604
UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSIS
MONCADA, S., & VANE, J. R. (1978) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a071482 · Cited by 441
Dusting, G. J., Moncada, S., & Vane, J. R. (1977) · Prostaglandins · doi:10.1016/0090-6980(77)90037-5 · Cited by 412
Thromboxanes: Selective Biosynthesis and Distinct Biological Properties
Needleman, P., Minkes, M. S., & Raz, A. (1976) · Science · doi:10.1126/science.945611 · Cited by 388
Self-citationCoronary Tone Modulation: Formation and Actions of Prostaglandins, Endoperoxides, and Thromboxanes
Needleman, P., Kulkarni, P. S., & Raz, A. (1977) · Science · doi:10.1126/science.831285 · Cited by 243
Self-citationApplication of imidazole as a selective inhibitor thromboxane synthetase in human platelets.
Needleman, P., Raz, A., Ferrendelli, J. A., & Minkes, M. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.4.1716 · Cited by 214
Self-citationPreparation and purification of lipid hydroperoxides from arachidonic and γ‐linolenic acids
Funk, M. O., Isaac, R., & Porter, N. A. (1976) · Lipids · doi:10.1007/bf02532660 · Cited by 212
Lapetina, E. G., Schmitges, C. J., Chandrabose, K. A., et al. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)91575-3 · Cited by 204
Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate
Kulkarni, P. S., Roberts, R., & Needleman, P. (1976) · Prostaglandins · doi:10.1016/0090-6980(76)90015-0 · Cited by 110
Self-citationThe synthesis of 1‐14C‐arachidonate and 3‐14C‐docosa‐7,10,13,16‐tetraenoate
Sprecher, H. W. (1971) · Lipids · doi:10.1007/bf02531170 · Cited by 40
Self-citation
Cited by
Omega-3 fatty acids in health and disease and in growth and development.
Simopoulos, A. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.438 · Cited by 2,162
Lee, T. H., Hoover, R. L., Williams, J. D., Sperling, R. I., Ravalese, J., Spur, B. W., Robinson, D. R., Corey, E. J., Lewis, R. A., & Austen, K. F. (1985) · New England Journal of Medicine · doi:10.1056/nejm198505093121903 · Cited by 1,333
Cardiovascular Effects of n-3 Fatty Acids
Leaf, A., & Weber, P. C. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803033180905 · Cited by 1,169
HÆMOSTATIC FUNCTION AND PLATELET POLYUNSATURATED FATTY ACIDS IN ESKIMOS
Dyerberg, J., & Bang, H. O. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91490-9 · Cited by 1,001
The eicosanoids and their biochemical mechanisms of action
Smith, W. L. (1989) · Biochemical Journal · doi:10.1042/bj2590315 · Cited by 871
Metadata
- Authors
- Needleman, P., Raz, A., Minkes, M. S., Ferrendelli, J. A., & Sprecher, H.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1979-02
- Volume
- 76
- Issue
- 2
- Pages
- 944-948
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2082951744
- Cited by
- 780
- References
- 15
- FWCI
- 9.74
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.